When Kim Trautman began experiencing symptoms of ALS, she was just 25 years old.
Β It would take nearly three more years before she received a diagnosis of a rare genetic form of ALS in October 2022, at the age of 28. For Kim, now 32, the long and frustrating road to a diagnosis reinforced the urgent need for greater awareness and understanding of ALS, particularly among young women.
Today, Kim is determined to use her experience to make a difference. Through sharing her story, participating in research, and connecting with other young women through Her ALS Story, a support group for women living with ALS, she hopes to help advance our understanding of the disease.
Kim describes her role in the Project ALS family as a "partner in crime". An important distinction: "We are committing good crime together!"
For Kim, that partnership means contributing wherever she can. Whether participating in research studies, completing surveys, or sharing her personal experiences, she knows that people living with ALS have an essential role to play in advancing scientific discovery.
Her own experience has made the importance of research especially personal. Because her diagnosis took so long, Kim was never eligible to participate in clinical trials. She hopes that continued research will lead to earlier diagnoses, giving more people with ALS the opportunity to access potential treatments and participate in clinical studies.
But Kim's hopes for research extend beyond finding a cure. She wants scientists to better understand the disease, identify potential biomarkers, investigate environmental factors, and learn which treatments work and which do not.
βThe more people with ALS who participate in research, the more scientists, researchers, and physicians can learn about ALS." she says. "We all play a crucial role."β
Kim Trautman
Looking Ahead
Kim finds hope in the many ways research could improve the lives of people living with ALS. New medications that slow disease progression, therapies that improve quality of life, and a deeper understanding of the disease would all represent meaningful progress.
Above all, she hopes for greater recognition that ALS can affect anyone, regardless of age or background.
"ALS is not exclusive," she reminds us.
Kim's story is a powerful reminder that advancing ALS research takes more than scientists working in laboratories. It takes people like Kim, who generously share their experiences, contribute to research, and advocate for a better future for everyone affected by ALS.
Everyone has a role in ALS research. And every role brings us closer to a world without ALS.
